Skylight Health Group Announces Closing of $13.8 Million Bought Deal Financing

by NASDAQ Market News December 30, 2020

NASDAQ Market News
Click here to email author

Skylight Health Announces Closing of Tennessee Clinic with $2.2 Million in Revenue and Positive EBITDA

Idebenone: A Synthetic Short-Chain Benzoquinone and a Substrate for the Enzyme NAD(P)H:quinone oxidoreductase (NQO1) – Global Drug Insight and Market Forecasts 2017-2030

Ads